Latest News

Date Title Topic
04 Jan 2016 Colorectal Cancer in Young Adults: the Focus on Hereditary Cancer Syndromes
21 Dec 2015 European Medicines Agency Recommends Two New Indications for Ramucirumab Lung and other thoracic tumours - Gastrointestinal cancers - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Osimertinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Necitumumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends to Extend Therapeutic Indications for Erlotinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 Trastuzumab-emtansine Too Costly for Use on the NHS England Breast cancer - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
21 Dec 2015 ESMO Asia 2015 News: Pembrolizumab ‘New Standard-Of-Care’ In Advanced NSCLC After Platinum-based Chemotherapy Lung and other thoracic tumours
21 Dec 2015 ESMO Asia 2015 News: Improved Outcomes With Afatinib Versus Gefitinib In EGFR-Mutant NSCLC Lung and other thoracic tumours
20 Dec 2015 ESMO Asia 2015 News: RADIANT-4 Supports Everolimus in Neuroendocrine Tumour Patients Gastrointestinal cancers
20 Dec 2015 ESMO Asia 2015 News: Cancer-associated Venous Thromboembolism Incidence Underestimated Palliative and supportive care
19 Dec 2015 ESMO Asia 2015 Press Release: Afatinib a Better Choice for EGFR-Mutated Lung Cancer in First-Line Lung and other thoracic tumours - Anticancer agents & Biologic therapy
19 Dec 2015 ESMO Asia 2015 Press Release: More Patients with Lung Cancer Could Benefit from Immunotherapy, Study Shows Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
19 Dec 2015 ESMO Asia 2015 Highlights: Gastric Cancer is Still an Unmet Medical Need in Both Europe and Asia Gastrointestinal cancers
19 Dec 2015 ESMO Asia 2015 News: Durvalumab, Tremelimumab Duo Promising in Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
18 Dec 2015 ESMO Asia 2015 Press Release: Asian Women with Endocrine-Resistant Breast Cancer Benefit from Combination Therapy Breast cancer - Anticancer agents & Biologic therapy